lercanidipine has been researched along with ascorbic acid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ghiadoni, L; Magagna, A; Salvetti, A; Salvetti, G; Taddei, S; Versari, D; Virdis, A | 1 |
1 trial(s) available for lercanidipine and ascorbic acid
| Article | Year |
|---|---|
Calcium antagonist treatment by lercanidipine prevents hyperpolarization in essential hypertension.
Topics: Antioxidants; Ascorbic Acid; Calcium Channel Blockers; Dihydropyridines; Endothelium, Vascular; Female; Forearm; Humans; Hypertension; Male; Middle Aged; Nitric Oxide; Oxidative Stress; Regional Blood Flow; Vasodilation | 2003 |